Design of hypoxic cell radiosensitizer utilized for hypoxia orientation of macrophage
Design of hypoxic cell radiosensitizer utilized for hypoxia orientation of macrophage
批准号:
14370758
负责人:
HORI Hitoshi
金额:
$4.54万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
我们设计了一种新的缺氧细胞放射增敏剂TX-2068,用于巨噬细胞的缺氧定向。TX-2068有一个n -乙酰半乳糖胺片段作为巨噬细胞识别组,TX-1877片段作为放射致敏组。以乙酰化n -乙酰半乳胺和TX-1877为原料,以BF3为催化剂,脱保护o -乙酰基,缩合合成了TX-2068,总收率为35%。TX-2068的水-辛醇分配系数(Poct)为Poct = 0.0010,水溶性较TX-1877的Poct = 0.056高。与EMT6/KU细胞的增强比(ER)为1.88 (1 mM),与TX-1877的ER = 1.75 (1 mM)相比,TX-2068的放射增敏活性略高。通过巨噬细胞吞噬活化实验评价TX-2068对巨噬细胞的活化程度。结果表明,当使用TX-2068时,吞噬活性增加至1mm,在5mm时下降。我们认为这种行为是在免疫反应中常见的钟形激活曲线,TX-2068被巨噬细胞激活。此外,MTT法在5 mM内未观察到TX-2068巨噬细胞的细胞毒性。综上所述,我们认为TX-2068是一种具有放射增敏活性和巨噬细胞吞噬活性的双功能药物,无细胞毒性。最后完成了“用于巨噬细胞缺氧定向的缺氧细胞放射增敏剂的设计”的科研工作。
英文摘要
We designed a novel hypoxic cell radiosensitizer TX-2068 that utilize for hypoxia orientation of macrophage. TX-2068 has a N-acetylgalactosamine moiety as a macrophage recognition group and TX-1877 moiety as a radiosensitizing group. We synthesized TX-2068 at condensation reaction with acetylated N-acetylgalactosamine and TX-1877 using BF3 as a catalyst followed by deprotection of O-acetyl group, TX-2068 was obtained by the total yield 35%. Water-octanol distribution coefficient (Poct) of TX-2068 was Poct = 0.0010, and a very high water solubility was shown compared with Poct = 0.056 of TX-1877. Radiosensitizing activity of TX-2068 was indicated as a enhancement ratio (ER) = 1.88 (1 mM) with EMT6/KU cell, and a little high sensitization revitalization was shown compared with ER = 1.75 (1 mM) of TX-1877. The degree of macrophage activation of TX-2068 was evaluated by macrophage phagocytic activation experiment. As a result, phagocytic activity was increased by the use of TX-2068 up to 1 mM and decreased at 5 mM. We suggested that this behavior is the bell-sharp type activation curve as a generally seen in immune reaction, and TX-2068 be activated of the macrophage. Besides, cytotoxicity for the macrophage cell of TX-2068 was not observed up to 5 mM at MTT method. From the all above-mentioned results, we concluded that TX-2068 is a bifunctional drug having radiosensitizing activity and macrophage phagocytic activity without cytotoxicity. Finally we finish the scientific research titled "Design of hypoxic cell radiosensitizer utilized for hypoxia orientation of macrophage".
期刊论文(120)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Beneficial effect of macrophage activating agent NK-4 on Thai HIV-infected patients.
巨噬细胞激活剂 NK-4 对泰国 HIV 感染者的有益作用。
DOI:
--
发表时间:
2003
期刊:
Anticancer Research 23
影响因子:
--
作者:
[Maekawa, S. et al., Yoshinori Nakagawa]
通讯作者:
Yoshinori Nakagawa
Synthesis of the new mannosidase inhibitor, diversity-oriented 5-substituted swainsonine analogues, via stereoselective Mannich reaction.
通过立体选择性曼尼希反应合成新型甘露糖苷酶抑制剂、面向多样性的 5-取代苦马豆素类似物。
DOI:
--
发表时间:
2004
期刊:
Organic Letters 6
影响因子:
--
作者:
[Yoshikawa, M., et al., Tomoya Fujita]
通讯作者:
Tomoya Fujita
Gcタンパク質(ビタミンD結合タンパク質)の糖鎖プロセシングをベースにしたドラマタイプがん治療薬の創製
基于 Gc 蛋白(维生素 D 结合蛋白)的聚糖加工创建戏剧型癌症疗法
DOI:
--
发表时间:
2004
期刊:
放射線生物研究 39
影响因子:
--
作者:
[堀 均]
通讯作者:
堀 均
Synthesis of the new mannosidase inhibitor, diversity-oriented 5-substiruted swainsonine analogues, via stereoselective Mannich reaction.
通过立体选择性曼尼希反应合成新型甘露糖苷酶抑制剂、面向多样性的 5-取代苦马豆素类似物。
DOI:
--
发表时间:
2004
期刊:
Organic Letters 6,5
影响因子:
--
作者:
[Ken-ichiro Kondo et al., Tomoya Fujita]
通讯作者:
Tomoya Fujita
Mohamad, S.B.: "Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation"Comp. Biochem. Physiol. A. Vol.132. 1-8 (2002)
Mohamad, S.B.:“肿瘤细胞 α-N-乙酰氨基半乳糖苷酶活性及其参与 GcMAF 相关巨噬细胞激活”Comp.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 47 条
Development of boron trace drug with broad molecule pursuit and destructive power by neutron irradiation
-
批准号:24659566
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2012
-
负责人:HORI Hitoshi
-
依托单位:
Molecular design of anticancer drug, α-NaGalase inhibitors for immunopotentiation
-
批准号:10672090
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1998
-
负责人:HORI Hitoshi
-
依托单位:
Slow-growth/hypoxic cell-directed design of multifunctional antitumor agents
-
批准号:08672561
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1996
-
负责人:HORI Hitoshi
-
依托单位:
Design of Anti-ischemic drug based on their effects in liver mitochondria of the turtle as an anaerobiosis model.
-
批准号:02671001
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1990
-
负责人:HORI Hitoshi
-
依托单位:
国内基金
海外基金
Macrophage和Treg在移植免疫调节中的相互作用及其机制研究
-
批准号:81102247
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:丁晨光
-
依托单位: